1. Introduction

Occupational safety in biotechnology laboratories in Morocco is an important area of labour law, public health law, environmental protection and biosecurity regulation. Biotechnology laboratories work with potentially hazardous biological materials, including genetically modified organisms (GMOs), bacteria, viruses, human biological samples, cell cultures, recombinant DNA, chemicals and infectious agents.

Employees working in these laboratories may face several occupational hazards:

Biological hazards: exposure to bacteria, viruses, fungi and pathogenic microorganisms.

Chemical hazards: exposure to toxic reagents, solvents and disinfectants.

Genetic engineering hazards: accidental release or exposure to genetically modified organisms.

Physical hazards: radiation, extreme temperatures, pressure systems and laboratory equipment.

Occupational health hazards: respiratory infections, skin diseases, allergic reactions and accidental needle-stick injuries.

Moroccan law addresses these risks through general workplace health and safety legislation, environmental protection rules, public health requirements and applicable international labour standards.

The central legal principle is that employers and laboratory operators must take appropriate preventive measures to protect workers, maintain safe laboratory conditions and control risks arising from biological and chemical research.

An important distinction is that Morocco's general occupational safety legislation does not constitute a single comprehensive biotechnology-laboratory statute. The legal framework must therefore be understood through several interconnected laws and regulations.

2. Main Legislative Framework in Morocco

A. Moroccan Labour Code – Law No. 65-99 of 2003

The principal legislation is Law No. 65-99 concerning the Moroccan Labour Code, promulgated by Dahir No. 1-03-194 of 11 September 2003.

Title IV of Book II, particularly Articles 281–344, establishes the framework for workplace hygiene and occupational safety.

Its provisions are directly relevant to biotechnology laboratories.

Article 24 – General employer responsibility

Article 24 requires employers to take necessary measures to preserve the safety, health and dignity of employees while they perform their assigned duties.

In a biotechnology laboratory, this responsibility includes:

Providing safe working conditions.

Preventing exposure to dangerous biological substances.

Providing appropriate protective equipment.

Informing employees about workplace hazards.

Establishing procedures for laboratory emergencies.

Article 281 – Workplace hygiene

Article 281 requires employers to maintain workplace cleanliness and provide hygienic conditions necessary for employee health.

It specifically addresses ventilation, lighting, fire prevention, drinking water, wastewater disposal, dust, vapours and sanitation.

For biotechnology laboratories, this provision supports requirements for:

Proper laboratory ventilation.

Regular disinfection of working surfaces.

Safe disposal of contaminated materials.

Appropriate washing and sanitation facilities.

Prevention of airborne biological contamination.

Article 282 – Workplace safety

Article 282 requires workplaces to be arranged to guarantee employee safety. Machinery, tools and equipment must have effective protective devices and be maintained in safe operating condition.

This is relevant to centrifuges, autoclaves, biosafety cabinets, laboratory refrigerators, sterilisation equipment and other potentially dangerous machinery.

Article 288 and related provisions – Dangerous work

The Labour Code also contains provisions addressing dangerous work and the protection of employees against occupational hazards. These provisions must be read together with the specific regulations governing hazardous substances and biological agents.

WIPO+2

B. Ministerial Order No. 93-08 of 12 May 2008

This Order establishes general and specific implementing measures relating to Articles 281–291 of the Labour Code.

It covers:

Organisation and arrangement of workplace premises.

Hygiene and safety inside workplaces.

Ventilation, heating and lighting.

Prevention of risks caused by noise.

Fire prevention.

Prevention of workplace accidents.

For biotechnology laboratories, the Order is particularly relevant to laboratory layout, emergency exits, ventilation systems, fire extinguishers and safe working arrangements.

The requirements should be adapted to the nature of the laboratory's activities and the hazards involved.

Natlex

C. Decree No. 2-12-431 of 25 November 2013

Particularly important for biotechnology laboratories

Decree No. 2-12-431 establishes conditions for the use of substances and preparations capable of harming employees' health or compromising their safety.

It is especially important because it addresses two major categories:

Chemical risks.

Biological risks.

The Decree provides for:

Assessment of occupational risks.

Preventive measures.

Information and training of employees.

Medical surveillance.

Measures to control exposure to hazardous substances and biological agents.

In biotechnology laboratories, it is relevant to pathogenic microorganisms, biological specimens, laboratory cultures and dangerous chemical reagents.

For example, where laboratory employees handle infectious microorganisms, the employer should assess exposure risks and implement appropriate containment, protective and hygiene procedures.

Natlex

D. Decree No. 2-12-236 of 25 November 2013

This Decree regulates the conditions for using machinery and equipment that may harm employees' health or compromise their safety.

It is relevant to:

High-speed centrifuges.

Autoclaves.

Laboratory pressure systems.

Sterilisation equipment.

Industrial biotechnology processing machinery.

Laboratory operators should ensure that equipment is appropriately maintained, protected and used by trained personnel.

Natlex

E. Law No. 18-12 on Compensation for Workplace Accidents

Law No. 18-12 of 2014 regulates compensation for occupational accidents and related injuries.

It provides a framework for compensation, medical expenses and other benefits when workers suffer qualifying workplace accidents.

For biotechnology laboratories, examples include:

Accidental exposure to infectious biological material.

Chemical burns.

Injuries caused by laboratory equipment.

Accidents during the handling of biological samples.

Other injuries arising from or occurring in connection with employment.

Employers must comply with applicable workplace accident insurance and reporting requirements.

The law was amended by Law No. 27-23 in 2025, so its current consolidated version should be consulted when determining particular compensation entitlements.

Détail Document+2

3. Regulation of Biological Hazards in Biotechnology Laboratories

Biological hazards are among the most important occupational safety concerns in biotechnology research.

Examples include:

Employer's preventive obligations

Under the Labour Code and Decree No. 2-12-431, employers should establish suitable protective arrangements, including:

Risk assessment before starting potentially hazardous activities.

Appropriate containment and laboratory access controls.

Safe handling and storage of biological materials.

Suitable personal protective equipment.

Decontamination and sterilisation procedures.

Training in biological hazard management.

Medical surveillance appropriate to the occupational risks.

Emergency response and exposure reporting procedures.

Biosafety levels

International biosafety practice commonly distinguishes four containment levels:

Work Spaces - Science Discovery Zone - Toronto Metropolitan University (TMU)

BSL-1 – Basic containment

Used for work involving biological agents not ordinarily associated with disease in healthy adults.

京都大学・京都府立医科大学近接のP2/BSL-2対応シェア型ウェットラボ 「Share Lab EVER SHIMOGAMO」2026年度：入居募集を開始 | 人と情報の交流掲示板 | LINK-J

BSL-2 – Moderate containment

Used for biological agents presenting moderate potential hazards, requiring controlled access and appropriate protective measures.

P3、P4 實驗室特點是內部的負壓呈梯度分布，愈往裡面壓力愈低 ，以防止氣流外洩。此外，實驗室必須具備高壓滅菌鍋，實驗用品必須經過高溫高壓、蒸氣滅菌之後才能取出，人員進與出也有規定的路線。 圖│研之有物 - 國家地理雜誌官方網站｜探索自然、科學與文化的最佳權

BSL-3 – High containment

Used for work involving agents that can cause serious disease, particularly where inhalation exposure is a concern.

España estrena su primer laboratorio de máxima bioseguridad para investigar los virus más letales | El PAÍS Exprés | EL PAÍS

BSL-4 – Maximum containment

Used for work involving dangerous agents associated with serious disease and requiring maximum containment.

These four levels are internationally recognised technical classifications, not a claim that Morocco has enacted a separate statutory four-level classification for every biotechnology laboratory.

Their application should be determined by the biological agent, activity, exposure route and applicable authorisation requirements.

4. Occupational Medical Surveillance and Employee Protection

Medical surveillance is essential because some biological exposures may produce symptoms only after an incubation period.

The Moroccan Labour Code establishes occupational medical requirements, particularly through Articles 304–327.

Article 304 – Occupational medical services

The Labour Code provides for occupational medical services in enterprises falling within its scope and establishes the framework for medical supervision of employees.

Article 327 – Medical examinations

Article 327 provides for medical examinations, including:

Medical examination before or shortly after recruitment, within the statutory period.

Periodic medical examinations.

Additional examinations for employees exposed to occupational hazards.

Medical examinations following certain periods of absence due to illness or workplace accidents.

For biotechnology laboratories, occupational medical surveillance may include assessment of respiratory symptoms, skin conditions, exposure incidents and other health effects relevant to the biological or chemical hazards involved.

Ma Loi+1

Personal protective equipment (PPE)

Laboratory employers should provide suitable protective equipment according to the risks identified.

Office of Research Safety | The George Washington University

Microbiologics Expands its Biosafety Level 3 Laboratory

Scientist Using an Automatic Pipette

10

Examples include:

Laboratory coats and protective gowns.

Chemical-resistant gloves.

Appropriate respiratory protection.

Safety goggles and face shields.

Protective footwear.

Specialised protective suits where necessary.

PPE should be selected according to the hazard and should not replace engineering controls, containment or safe working procedures.

5. Laboratory Waste Management and Environmental Safety

Biotechnology laboratories generate waste that may create risks for employees, waste handlers and the surrounding community.

Examples include:

Infectious biological waste.

Contaminated needles and sharps.

Chemical waste.

Genetically modified biological materials.

Contaminated laboratory equipment.

Biological cultures and expired specimens.

Relevant Moroccan legislation

Law No. 28-00 on Waste Management and Disposal

This legislation establishes a framework for waste classification, collection, transportation, treatment and disposal.

Biotechnology laboratories must ensure that hazardous waste is handled through appropriate procedures and that dangerous waste does not create unacceptable risks to workers or the environment.

Law No. 11-03 on the Protection and Enhancement of the Environment

This law provides general environmental protection principles relevant to pollution prevention and the management of activities that may adversely affect the environment.

Law No. 12-03 on Environmental Impact Studies

This law is relevant where a biotechnology facility or associated project falls within the statutory environmental impact assessment requirements.

The distinction is important: these environmental laws complement occupational safety legislation; they do not replace the employer's direct responsibilities under the Labour Code.

6. Institutional Authorities Responsible for Occupational Safety

Several institutions have responsibilities relevant to workplace safety in Morocco.

Role of the Labour Inspectorate

Labour inspectors play an important role in monitoring compliance with occupational safety requirements.

They may examine workplace conditions, review relevant records, investigate complaints and take action within their statutory powers.

In biotechnology facilities, inspections may concern:

Biological exposure controls.

Workplace ventilation.

Employee training.

Protective equipment.

Machinery safety.

Workplace accident documentation.

Medical surveillance arrangements.

7. Safety and Hygiene Committees

Articles 336–343 of the Labour Code establish an important workplace safety governance mechanism.

Under Article 336, enterprises within the specified industrial, commercial, craft and agricultural categories employing at least 50 workers must establish a Safety and Hygiene Committee.

The committee includes representatives of the employer, the occupational safety function, the occupational physician, employee representatives and, where applicable, trade union representatives.

Functions under Article 338

The committee is responsible for:

Identifying occupational hazards.

Ensuring implementation of applicable health and safety legislation.

Monitoring protective equipment.

Promoting safe working methods.

Improving workplace conditions.

Supporting protection of the environment within and around the enterprise.

Accident investigations

Article 340 requires the committee to investigate workplace accidents and occupational diseases.

Article 341 requires the relevant investigation report to be sent to the labour inspector and the occupational medical inspector within 15 days following the accident or the establishment of the occupational disease.

Article 342 requires an annual report concerning the development of occupational risks.

Article 343 provides for the maintenance of specified safety records.

These provisions are particularly significant for biotechnology laboratories because an exposure incident may affect not only the individual employee but also other laboratory personnel and potentially the surrounding environment.

WIPO+2

8. Important Moroccan Case Laws and Judicial Principles

An important research qualification is necessary: there is no readily identifiable published Moroccan Supreme Court judgment specifically establishing a biotechnology-laboratory biosafety standard under Decree No. 2-12-431.

Nevertheless, Moroccan workplace accident jurisprudence provides relevant legal principles for biotechnology laboratory disputes.

Case 1: Moroccan Court of Cassation, 10 September 1990, Decision No. 2065

Relevant occupational accident precedent

Reference: Cour de cassation, 10 September 1990, No. 2065, Case No. 9570/89.

Legal issue: Whether an accident occurring at the workplace could qualify as an occupational accident despite questions concerning the immediate medical cause of the injury or death.

Judicial principle:

The Court applied Article 3 of the former Dahir of 6 February 1963 concerning compensation for workplace accidents.

It recognised that an accident occurring at the workplace could qualify as an occupational accident regardless of its cause, unless the employer or insurer established the relevant pathological condition of the victim.

Relevance to biotechnology laboratories:

Suppose a laboratory technician suffers a serious injury following exposure to a dangerous biological substance while performing assigned duties.

The decision supports the importance of examining the occupational circumstances of the incident rather than rejecting the occupational connection merely because another medical factor is involved.

The current compensation framework is now principally governed by Law No. 18-12, rather than the former 1963 legislation.

Jurisprudence+2

Case 2: Moroccan Court of Cassation, 24 June 2009, Decision No. 797

Reference: Cour de cassation, Social Chamber, 24 June 2009, No. 797, Case No. 1078/5/1/2008.

Legal issue: Proof of a workplace accident.

Judicial principle:

The Court recognised that a workplace accident is a material fact that may be established through different forms of evidence.

The decision also recognised the evidentiary significance of the employer's declaration of the accident.

Relevance to biotechnology laboratories:

Consider a laboratory technician who suffers a needle-stick injury while handling a biological sample.

Relevant evidence may include:

Accident reports.

Laboratory incident registers.

Medical records.

Witness statements.

Employer declarations.

Exposure investigation reports.

Relevant laboratory access and safety records.

The decision supports a flexible evidentiary approach when establishing the occurrence of an occupational accident.

Jurisprudence

Case 3: Moroccan Court of Cassation, 15 October 1990, Decision No. 2359

Reference: Cour de cassation, 15 October 1990, No. 2359.

Legal issue: Revision of compensation awarded for an occupational accident.

Judicial principle:

The Court considered the time limit for requesting revision of an occupational accident compensation annuity under the former 1963 legislation.

The decision recognised that a subsequent decision fixing the annuity could start a new period for requesting its revision.

Relevance to biotechnology laboratories:

An employee may develop a lasting occupational impairment after an exposure incident. Where the applicable compensation legislation permits revision because of a change in the employee's condition, the case illustrates the importance of preserving medical evidence and compensation records.

The historical limitation ruling should not be treated as a statement of the current limitation period under Law No. 18-12.

Jurisprudence+1

Legal significance of these cases

The three decisions provide useful principles concerning:

Recognition of occupational accidents.

Evidence of workplace injuries.

Medical causation.

Compensation for occupational injury.

Subsequent changes in an injured worker's condition.

They are analogous occupational accident precedents, not direct judicial rulings on modern biotechnology containment standards.

9. Employer Liability for Biotechnology Laboratory Accidents

Employers may face different forms of legal responsibility when laboratory employees suffer injury because of unsafe working conditions.

A. Civil liability

Civil liability may arise where an employer's negligence or breach of an applicable legal duty causes injury.

Examples include:

Failure to maintain laboratory equipment.

Failure to provide appropriate protective equipment.

Failure to implement necessary containment procedures.

Failure to provide adequate employee training.

Failure to respond appropriately to known exposure risks.

The applicable civil liability principles must be considered alongside the special compensation regime under Law No. 18-12.

B. Labour law liability

An employer may face labour law consequences for failing to comply with statutory workplace hygiene and safety requirements.

Article 344 of the Labour Code provides penalties for non-compliance with the provisions of the relevant chapter on Safety and Hygiene Committees.

C. Occupational accident compensation

Under Law No. 18-12, qualifying occupational accidents may give rise to:

Medical treatment expenses.

Temporary incapacity compensation.

Permanent incapacity benefits.

Compensation for qualifying consequences of workplace accidents.

Benefits for eligible dependants in the event of a worker's death.

The employer's applicable insurance and reporting obligations must also be observed.

D. Criminal liability

Depending on the facts, serious incidents may also raise criminal law questions, particularly where conduct constitutes an independently punishable offence, such as negligent injury, unlawful conduct or serious breaches of applicable safety requirements.

Criminal liability should not automatically be inferred from every laboratory accident. The relevant offence, fault requirements and causal connection must be established.

10. International Standards and Morocco's Obligations

International labour and biosafety standards provide additional guidance for Moroccan biotechnology laboratories.

An important distinction concerns ratification.

Morocco ratified ILO Convention No. 187 on 14 June 2019 but has not ratified ILO Convention No. 155, according to the ILO's NORMLEX information.

Therefore, Convention No. 187 is an international treaty obligation for Morocco, whereas Convention No. 155 should be treated as an international reference rather than a ratified treaty obligation.

International Labour Organization+2

The WHO Laboratory Biosafety Manual also provides useful technical guidance for risk assessment, laboratory containment, personal protective equipment, waste management and exposure prevention.

11. Practical Compliance Requirements for Biotechnology Laboratories in Morocco

A biotechnology laboratory should develop a comprehensive occupational safety programme.

Example: Accidental exposure to genetically modified bacteria

Consider a Moroccan biotechnology laboratory conducting research involving genetically modified bacteria.

A laboratory technician accidentally spills a biological culture and experiences direct skin exposure.

The legal response should involve the following steps:

Immediately implement the laboratory's exposure and containment procedures.

Provide appropriate medical assessment and treatment.

Record the incident and identify the biological material involved.

Investigate the cause of the accident.

Assess whether other laboratory employees were exposed.

Notify the relevant authorities where legally required.

Review the adequacy of training, protective equipment and containment measures.

Implement corrective measures to prevent recurrence.

The employer's obligations arise principally from the Labour Code and Decree No. 2-12-431, together with any other applicable biosafety and environmental requirements.

12. Major Legal Challenges in Morocco

Despite the existence of general occupational safety legislation, biotechnology laboratories present several regulatory challenges.

1. Absence of a unified biotechnology workplace safety statute

Morocco relies on several general labour, environmental, health and safety instruments. This can make compliance complicated for specialised laboratories.

2. Emerging biotechnology risks

Gene editing, synthetic biology, engineered microorganisms and advanced cell therapies create risks that may require more specialised technical guidance.

3. Limited specialised judicial precedents

The published Moroccan decisions identified above concern general workplace accidents rather than biotechnology-specific exposure incidents.

4. Risk assessment difficulties

Laboratories may encounter difficulties assessing risks from newly developed organisms or technologies for which long-term exposure data is limited.

5. Employee training

Effective safety regulation requires specialised training for laboratory technicians, researchers, supervisors and waste-management personnel.

6. Medical and scientific evidence

Determining whether an occupational disease resulted from a particular biological exposure may require specialised medical expertise, laboratory records and scientific evidence.

13. Recommendations for Strengthening Moroccan Biotechnology Laboratory Safety

Morocco could strengthen occupational protection through the following measures:

Develop specialised biosafety guidance for biotechnology research institutions.

Establish clear technical criteria for biological containment levels.

Improve inspection capacity for laboratories handling hazardous biological agents.

Introduce standardised biological exposure reporting procedures.

Strengthen occupational medical surveillance.

Require documented risk assessments for high-risk biotechnology activities.

Improve coordination between labour, health and environmental authorities.

Promote internationally recognised laboratory safety management systems.

Improve protection for laboratory employees reporting unsafe practices.

Develop specialised training programmes for emerging biotechnology hazards.

14. Conclusion

Occupational safety in biotechnology laboratories in Morocco is governed by a combination of labour legislation, biological and chemical hazard regulations, environmental legislation and occupational accident compensation rules.

Law No. 65-99 establishes the fundamental responsibilities of employers concerning employee health and safety. Ministerial Order No. 93-08 provides workplace hygiene and safety requirements, while Decree No. 2-12-431 is particularly important because it addresses chemical and biological occupational risks.

Law No. 18-12 provides the framework for compensation following qualifying workplace accidents.

Moroccan Court of Cassation decisions, particularly Decisions Nos. 2065 of 1990 and 797 of 2009, provide useful judicial principles concerning occupational accident recognition and evidence.

Ultimately, biotechnology laboratory safety requires more than ordinary workplace hygiene. It requires systematic biological risk assessment, effective containment, employee training, appropriate medical surveillance, reliable incident reporting and proper waste management.

The most important legal principle is that biotechnology innovation must operate within a framework that protects laboratory employees, public health and the environment.

15. Important Legal References and Research Sources

The following materials are useful for further academic and legal research:

Moroccan Labour Code – Law No. 65-99 (WIPO Lex).

Ministerial Order No. 93-08 of 12 May 2008 (ILO NATLEX).

Decree No. 2-12-431 of 25 November 2013 (ILO NATLEX).

Decree No. 2-12-236 of 25 November 2013 (ILO NATLEX).

Law No. 18-12 on Occupational Accident Compensation.

ILO – Morocco's Ratification Record.

Moroccan Court of Cassation – Decision No. 2065.

Moroccan Court of Cassation – Decision No. 797.

Academic note: This analysis distinguishes enacted Moroccan legal requirements from international technical recommendations and analogous judicial precedents. For litigation or regulatory compliance, the latest Arabic texts published in Morocco's Official Gazette and their subsequent amendments should be checked.